Alembic Pharmaceuticals has informed its shareholders about the impending transfer of shares to the Investor Education and Protection Fund (IEPF) due to unclaimed dividends for seven consecutive years. This action is in accordance with Section 124(6) of the Companies Act, 2013.
The company has identified shares on which dividends have not been claimed since the financial year 2018-2019. Shareholders are urged to claim their unpaid dividends by 10th August 2026 to avoid the transfer of their shares to the IEPF. The unclaimed dividends for periods prior to the specified years have already been transferred to the IEPF as required by law.
Alembic Pharmaceuticals has provided details of the unclaimed dividends and the number of shares held by each shareholder. Shareholders can reclaim their dividends or seek clarification by contacting the company’s Registrar and Share Transfer Agents, MUFG Intime India Private Limited.
Additionally, shareholders holding shares in physical form are advised to register their KYC details if not already done. Necessary forms for registering or changing KYC details and nominations are available on the company’s website and the RTA’s website.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).